Todd C. Brady - CEO @ Aldeyra Therapeutics

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

Todd Brady is the Chief Executive Officer of Aldeyra Therapeutics. He attended Duke University School of Medicine.

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	NovaDigm Therapeutics	Domain Associates	—	Series B - NovaDigm Therapeutics	obfuscated obfuscation
obfuscated obfuscation	NovaDigm Therapeutics	Domain Associates	Yes	Series A - NovaDigm Therapeutics	obfuscated obfuscation

Number of Current Jobs

Number of Past Jobs

is the

CEO

. Additionally,

has had

past jobs including

Principal

Organization Name	Title At Company	Start Date	End Date
Domain Associates	Principal	—	2014
Aldexa Therapeutics	President and CEO	2011	—

Number of Current Board & Advisor Roles

holds

board and advisor roles as

Board Member

and

Board Member

Hub Name	CB Rank (Hub)
Developer Platform Companies With Fewer Than 100 Employees	12,394
Greater Boston Area Public Companies	18,131
New England Therapeutics Companies	27,465
Greater Boston Area Therapeutics Companies	37,590
Health Care Public Companies With Fewer Than 50 Employees	27,058
East Coast Biotechnology Public Companies	13,784
Therapeutics Public Companies With Fewer Than 1000 Employees	15,367
New England Public Companies	16,472
East Coast Developer Platform Companies	43,822
Greater Boston Area Companies With Fewer Than 10 Employees (Top 10K)	9,889

studied at